CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Grant or award Head of R&D and CMO acquired 8,000 shares (grant or award)
- 4 Open-market buy Director bought 2,500 shares at $16.00 ($40,000)
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer sold 1,085 shares at an average $23.42 ($25,408)
- 4 Planned sale Chief Medical Officer sold 5,035 shares at an average $22.95 ($115,546)
- 4 Planned sale CEO & President sold 5,658 shares at $18.88 ($106,823)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 2,586,928 shares at an average $25.20 ($65,184,894)
- 4 Planned sale Chief Commercial Officer sold 226 shares at $26.28 ($5,939)
- 4 Planned sale Chief Medical Officer sold 1,556 shares at $26.28 ($40,892)
- 4 Planned sale CEO & President sold 4,986 shares at $26.28 ($131,032)
- 4 Planned sale Chief Financial Officer sold 1,797 shares at $26.28 ($47,225)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 1 of 40 · 796 filings